Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Table of Contents: Oncotarget’s Volume 12, Issue 24

Oncotarget

November 23, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget: Volume 12, Issue 24. continue reading »

Behind the Study: P4HA1 Protein and Colorectal Cancer

Oncotarget

November 22, 2021
Dr. Michael Roehrl describes the research paper he co-authored, entitled, “Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer”. continue reading »

Chemical in Sunscreen Promotes Breast Cancer in Diet-Dependent Manner

Oncotarget

November 18, 2021
The bioactivity of oxybenzone—a harmful chemical often found in sunscreens—was examined within mouse models of breast cancer in high- and low-fat dietary contexts. continue reading »

Behind the Study: Benzophenone-3 Promotion of Mammary Tumorigenesis

Oncotarget

November 15, 2021
Dr. Richard Schwartz describes the 2020 research paper he co-authored, entitled, “Benzophenone-3 promotion of mammary tumorigenesis is diet-dependent.” continue reading »

New Study: ALK Rearrangement Among Lung Cancer Patients

Oncotarget

November 10, 2021
In Oncotarget’s Volume 12, Issue 23, cover paper, researchers retrospectively assessed the prevalence of anaplastic lymphoma kinase (ALK) gene rearrangement among nearly 20,000 patients with advanced non-small cell lung cancer. continue reading »